# Altman Z-Score Analysis Report: Clover Health Investments, Corp (CLOV)

---
## Introduction
This report provides a comprehensive, theory-informed financial health analysis of the selected company using the Altman Z-Score framework. It integrates quantitative diagnostics, turnaround management theory, and stakeholder recommendations, with all findings and recommendations grounded in referenced academic and industry sources. The analysis is generated by an expert LLM-driven pipeline, ensuring transparency, reproducibility, and robust source attribution.

**Author:** Fabio Correa

**Source Attribution:** This report and analysis pipeline are generated using the open-source Altman Z-Score Analysis project, available at [https://github.com/fabioc-aloha/Altman-Z-Score](https://github.com/fabioc-aloha/Altman-Z-Score).

**License:** This software is distributed under the Attribution Non-Commercial License (MIT-based). See the LICENSE file for details.

Disclaimer: The developer disclaims any responsibility for the accuracy, completeness, or consequences of the analysis and information provided by this software. All results are for informational purposes only and should not be relied upon for financial, investment, or legal decisions.
---

**Script Version:** v2.4

## Analysis Context and Z-Score Model Selection Criteria

- **Industry:** SIC 6324 (SIC 6324)
- **Ticker:** CLOV
- **Public:** True
- **Emerging Market:** False
- **Maturity:** Mature Company
- **Model:** original
- **Analysis Date:** 2025-05-30


## Z-Score Formula Used

Z = 6.56*X1 + 3.26*X2 + 6.72*X3 + 1.05*X4
- X1 = (Current Assets - Current Liabilities) / Total Assets
- X2 = Retained Earnings / Total Assets
- X3 = EBIT / Total Assets
- X4 = Equity / Total Liabilities

**Thresholds:**
- Safe Zone: > 2.6
- Grey Zone: > 1.1 and <= 2.6
- Distress Zone: <= 1.1



---

# Graphical View of the Z-Score Analysis


![Z-Score and Price Trend Chart](zscore_CLOV_trend.png)

*Figure: Z-Score and stock price trend for CLOV (image not available yet; will be generated after analysis)*


## Z-Score Component Table (by Quarter)
| Quarter   |    X1 |     X2 |     X3 |    X4 |   Z-Score | Diagnostic    |
|-----------|-------|--------|--------|-------|-----------|---------------|
| 2025 Q1   | 0.198 | -3.776 | -0.002 | 6.038 |    -4.683 | Distress Zone |
| 2024 Q4   | 0.223 | -3.793 | -0.037 | 5.476 |    -5.4   | Distress Zone |
| 2024 Q3   | 0.234 | -3.339 | -0.013 | 3.779 |    -5.471 | Distress Zone |
| 2024 Q2   | 0.334 | -3.221 |  0.011 | 1.467 |    -6.699 | Distress Zone |
| 2024 Q1   | 0.292 | -3.244 | -0.033 | 0.872 |    -7.965 | Distress Zone |
## Diagnostic Evaluation of Financial Health

### Liquidity
Clover Health Investments, Corp (CLOV) has demonstrated a liquidity ratio (X1) that fluctuates around 0.2, indicating that the company has limited ability to cover its short-term liabilities with its current assets. A liquidity ratio below 1 is concerning, as it suggests potential cash flow issues that could hinder operational capabilities.

### Profitability
The retained earnings ratio (X2) is negative, reflecting accumulated losses over time. This is a significant red flag, as it indicates that the company has not been able to generate sufficient profits to reinvest in its operations or provide returns to shareholders.

### Capital Efficiency
The EBIT to total assets ratio (X3) is also negative, suggesting that the company is not generating positive earnings before interest and taxes relative to its asset base. This inefficiency can lead to further financial distress as the company struggles to leverage its assets effectively.

### Leverage
The equity to total liabilities ratio (X4) is relatively high at approximately 6.0, indicating that CLOV has a significant amount of equity compared to its liabilities. While this may suggest a buffer against insolvency, the overall negative Z-Score indicates that the company is still in a precarious financial position.

### Z-Score Trend Interpretation
The Z-Score has consistently remained in the distress zone, with the latest score at -4.683 for Q1 2025. This downward trend indicates a worsening financial condition, necessitating immediate action to avert potential bankruptcy. The persistent negative scores across multiple quarters highlight the urgent need for a turnaround strategy.

---

## Turnaround and Renewal Management Theory Application

### Phased Response Proposal
1. **Immediate Retrenchment (Short-term Focus)**
   - **Cost Reduction:** Implement immediate cost-cutting measures, including layoffs and operational efficiencies, to stabilize cash flow. This aligns with Bibeault's (1999) emphasis on immediate financial stabilization during a turnaround.
   - **Asset Liquidation:** Identify non-core assets for divestiture to improve liquidity. Hofer (1980) suggests that asset sales can provide necessary cash to fund operations.

2. **Long-term Repositioning (Strategic Focus)**
   - **Market Reassessment:** Conduct a thorough market analysis to identify new growth opportunities and potential customer segments. Hoskisson et al. (2004) highlight the importance of strategic repositioning in corporate restructuring.
   - **Innovation and R&D Investment:** Allocate resources towards innovation to improve product offerings and customer engagement. Beard (2024) discusses the role of agile practices in fostering innovation within technology firms.

---

## Stakeholder Recommendations

| Stakeholder Title                     | Name (if available) | Responsibilities and Recommended Actions                                                                                                                                                                                                 |
|---------------------------------------|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Chief Executive Officer               | [CEO Name]          | Lead the turnaround strategy, focusing on immediate cost reductions and long-term innovation. Communicate transparently with all stakeholders about the company's challenges and recovery plans.                                           |
| Chief Financial Officer               | [CFO Name]          | Oversee financial restructuring, manage cash flow, and implement cost-cutting measures. Ensure accurate financial reporting to maintain stakeholder trust.                                                                                |
| Chief Marketing Officer               | [CMO Name]          | Reassess marketing strategies to target new customer segments. Develop campaigns that emphasize the company's commitment to recovery and innovation.                                                                                       |
| Board Members                         | [Board Members]     | Provide oversight and strategic guidance. Ensure that management is held accountable for the turnaround plan's execution and effectiveness.                                                                                                 |
| Employees                             | [Employee Group]    | Engage in open communication about the company's situation. Encourage feedback and ideas for operational improvements.                                                                                                                    |
| Investors                             | [Investor Group]    | Monitor the company's recovery efforts closely. Consider holding shares during the turnaround phase, as long-term value may be realized if the strategy is successful.                                                                      |
| Creditors                             | [Creditor Group]     | Work with management to restructure debt if necessary. Maintain open lines of communication regarding the company's financial health and recovery plans.                                                                                     |
| Debtors                               | [Debtor Group]       | Ensure timely payments to maintain cash flow. Engage with management to understand the company's recovery efforts and any potential impacts on service delivery.                                                                             |
| Partner Companies                     | [Partner Companies]  | Collaborate with CLOV to identify synergies and opportunities for joint ventures that can enhance market presence and operational efficiency.                                                                                               |
| Customers                             | [Customer Group]     | Maintain loyalty during the recovery phase. Provide feedback on products and services to help the company realign its offerings with market needs.                                                                                          |
| Regulators                            | [Regulatory Body]    | Ensure compliance with all regulatory requirements during the restructuring process. Facilitate communication to maintain trust and transparency.                                                                                             |
| Major Suppliers                       | [Supplier Group]     | Work with CLOV to ensure supply chain stability. Consider flexible payment terms to support the company's recovery efforts.                                                                                                               |

---

## Communication, Marketing, and Execution Strategies

### Communication Strategy
- **Internal Communication:** Regular updates to employees about the turnaround progress and financial health.
- **External Communication:** Transparent communication with investors and creditors about the recovery strategy and expected outcomes.

### Marketing Strategy
- **Rebranding:** Consider a rebranding initiative to signal a fresh start and commitment to innovation.
- **Customer Engagement:** Launch campaigns that highlight new products and services, focusing on customer needs and feedback.

### Execution Timeline
| Phase                 | Timeline        | Accountability                   |
|-----------------------|-----------------|----------------------------------|
| Immediate Retrenchment| 0-3 Months      | CEO, CFO                         |
| Market Reassessment    | 3-6 Months      | CMO, Board Members               |
| Innovation Investment  | 6-12 Months     | CMO, R&D Team                   |
| Review and Adjust     | Ongoing         | CEO, Board Members               |

---

## Investor Recommendation
Based on the current financial health and Z-Score analysis, investors should **hold** their positions in CLOV, as the company is in a distress zone but has potential for recovery if the proposed turnaround strategies are effectively implemented. However, this is not financial advice, and investors should consult their financial advisors before making any decisions.

---

## External Stakeholder Bargaining Power Assessment

| External Stakeholder          | Nature of Bargaining Power | Degree of Influence | Rationale                                                                                   |
|-------------------------------|----------------------------|---------------------|--------------------------------------------------------------------------------------------|
| Regulators                    | Regulatory Compliance       | High                | CLOV must adhere to regulations, which can impact operational flexibility and recovery plans. |
| Creditors                     | Financial Leverage          | High                | Creditors can influence restructuring terms and may demand immediate repayment or concessions. |
| Major Suppliers               | Supply Chain Dependence     | Medium              | Suppliers can affect operational capabilities through pricing and availability of materials. |
| Activist Investors            | Shareholder Influence       | Medium              | They can pressure management for changes in strategy or governance, impacting recovery efforts. |
| Large Customers               | Revenue Dependence          | Medium              | Large customers can influence revenue stability and demand for products/services.           |

---

## Disclaimer
**Disclaimer:**
Generative AI is not a financial advisor and can make mistakes. Consult your financial advisor before making investment decisions.
- LLM Model used: OpenAI GPT-3.5
- Knowledge cut-off: October 2023
- Internet search: No
- Real-time data: No

---

### References and Data Sources
- **Financials:** SEC EDGAR/XBRL filings, Yahoo Finance, and company quarterly/annual reports.
- **Market Data:** Yahoo Finance (historical prices, market value of equity).
- **Computation:** All Z-Score calculations use the Altman Z-Score model as described in the report, with robust error handling and logging.
- **Source Attribution:** This report and analysis pipeline are generated using the open-source Altman Z-Score Analysis project, available at [https://github.com/fabioc-aloha/Altman-Z-Score]. Author: Fabio Correa.
- **Theoretical Frameworks and Resources:**
  - Altman Z-Score Analysis Project (https://github.com/fabioc-aloha/Altman-Z-Score)
  - Hofer, C. W. (1980). Turnaround strategies. Journal of Business Strategy, 1(1), 19â€“31.
  - Bibeault, D. B. (1999). Corporate turnaround: How managers turn losers into winners. Beard Books.
  - Hoskisson, R. E., White, R. E., & Johnson, R. A. (2004). Corporate restructuring: Managing the strategy, structure, and process of change. McGraw-Hill Education.
  - Beard, D. (2024). Strategic renewal in technology firms: Agile practices and innovation. Journal of Organizational Change, 31(2), 145â€“160.
  - Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman.
  - Altman, E. I. (1968). Financial ratios, discriminant analysis and the prediction of corporate bankruptcy. Journal of Finance, 23(4), 589â€“609.
  - Altman, E. I., & Hotchkiss, E. (2006). Corporate financial distress and bankruptcy: Predict and avoid bankruptcy, analyze and invest in distressed debt (3rd ed.). Wiley.
  - Brigham, E. F., & Daves, P. R. (2021). Intermediate financial management (14th ed.). Cengage Learning.
  - Higgins, R. C. (2019). Analysis for financial management (12th ed.). McGraw-Hill Education.
  - Palepu, K. G., & Healy, P. M. (2020). Business analysis and valuation: Using financial statements (6th ed.). Cengage Learning.
  - Platt, H. D. (2004). Principles of corporate renewal (2nd ed.). University of Michigan Press.
  - Shepherd, D. A., & Rudd, J. M. (2014). The influence of ethical leadership on organizational renewal. Academy of Management Perspectives, 28(3), 257â€“275.



---

# Appendix

## Raw Data Field Mapping Table (by Quarter)
| Quarter   | Canonical Field     | Mapped Raw Field                        | Value (USD millions)   |
|-----------|---------------------|-----------------------------------------|------------------------|
| 2025 Q1   | total_assets        | Total Assets                            | 583.7                  |
| 2025 Q1   | current_assets      | Current Assets                          | 331.4                  |
| 2025 Q1   | current_liabilities | Current Liabilities                     | 215.7                  |
| 2025 Q1   | retained_earnings   | Retained Earnings                       | -2,204.1               |
| 2025 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 247.6                  |
| 2025 Q1   | book_value_equity   | Common Stock Equity                     | 336.1                  |
| 2025 Q1   | ebit                | EBIT                                    | -1.3                   |
| 2025 Q1   | sales               | Total Revenue                           | 462.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q4   | total_assets        | Total Assets                            | 580.7                  |
| 2024 Q4   | current_assets      | Current Assets                          | 343.1                  |
| 2024 Q4   | current_liabilities | Current Liabilities                     | 213.5                  |
| 2024 Q4   | retained_earnings   | Retained Earnings                       | -2,202.8               |
| 2024 Q4   | total_liabilities   | Total Liabilities Net Minority Interest | 239.6                  |
| 2024 Q4   | book_value_equity   | Common Stock Equity                     | 341.1                  |
| 2024 Q4   | ebit                | EBIT                                    | -21.5                  |
| 2024 Q4   | sales               | Total Revenue                           | 337.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q3   | total_assets        | Total Assets                            | 653.0                  |
| 2024 Q3   | current_assets      | Current Assets                          | 432.7                  |
| 2024 Q3   | current_liabilities | Current Liabilities                     | 279.6                  |
| 2024 Q3   | retained_earnings   | Retained Earnings                       | -2,180.7               |
| 2024 Q3   | total_liabilities   | Total Liabilities Net Minority Interest | 310.8                  |
| 2024 Q3   | book_value_equity   | Common Stock Equity                     | 342.2                  |
| 2024 Q3   | ebit                | EBIT                                    | -8.8                   |
| 2024 Q3   | sales               | Total Revenue                           | 331.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q2   | total_assets        | Total Assets                            | 674.2                  |
| 2024 Q2   | current_assets      | Current Assets                          | 549.6                  |
| 2024 Q2   | current_liabilities | Current Liabilities                     | 324.5                  |
| 2024 Q2   | retained_earnings   | Retained Earnings                       | -2,171.6               |
| 2024 Q2   | total_liabilities   | Total Liabilities Net Minority Interest | 349.3                  |
| 2024 Q2   | book_value_equity   | Common Stock Equity                     | 324.9                  |
| 2024 Q2   | ebit                | EBIT                                    | 7.2                    |
| 2024 Q2   | sales               | Total Revenue                           | 356.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q1   | total_assets        | Total Assets                            | 671.8                  |
| 2024 Q1   | current_assets      | Current Assets                          | 552.7                  |
| 2024 Q1   | current_liabilities | Current Liabilities                     | 356.4                  |
| 2024 Q1   | retained_earnings   | Retained Earnings                       | -2,179.0               |
| 2024 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 379.3                  |
| 2024 Q1   | book_value_equity   | Common Stock Equity                     | 292.5                  |
| 2024 Q1   | ebit                | EBIT                                    | -22.4                  |
| 2024 Q1   | sales               | Total Revenue                           | 346.9                  |

All values are shown in millions of USD as reported by the data source.

